{
    "Case ID": "073554",
    "Crime_Name": [
        "Patent Infringement"
    ],
    "Crime_Type": [
        "Property Crimes"
    ],
    "Dispute_Type": [
        "Patent infringement dispute"
    ],
    "Legal_Issue": [
        "Whether Cobalt's process infringes Bayer's '137 patent"
    ],
    "Governing_Law": [
        "Patent law"
    ],
    "Procedural_Stage": [
        "Application stage"
    ],
    "Evidence_Assessment": [
        "Cobalt's process does not use ruthenium salts or produce claimed intermediate compounds"
    ],
    "Decision_Outcome": [
        "Bayer's application dismissed"
    ],
    "Burden_of_Proof": [
        "On Bayer to prove infringement"
    ],
    "Credibility_Factor": [],
    "Legal_Rule": [
        "A product-by-process claim includes the process if it is essential to the invention, and infringement requires using the patented process"
    ],
    "Standard_of_Review": [
        "Claim construction and technical comparison"
    ],
    "Procedural_Issue": [],
    "Grounds_for_Claim": [
        "Alleged infringement of '137 patent by Cobalt"
    ],
    "Outcome_on_Merits": [
        "Cobalt did not infringe the '137 patent"
    ],
    "Decision_Maker": [
        "Court"
    ],
    "Judicial_Review_Outcome": [
        "No infringement found"
    ],
    "Review_Standard": [
        "Technical and legal interpretation of patent claims"
    ],
    "Procedural_Fairness_Assessment": [],
    "Key_Evidence_Considered": [
        "Presence of ruthenium salts as essential element in patented process",
        "Cobalt's manufacturing process details"
    ],
    "Legal_Framework": [
        "Patent law framework for product-by-process claims"
    ],
    "Applicant_Challenge": [
        "Bayer sought to prohibit Cobalt from marketing generic YASMINÂ®"
    ],
    "Court_Result": [
        "Dismissal of Bayer's application"
    ],
    "Legal_Rule_Source": [
        "Case law and statutory patent provisions"
    ],
    "Standard_of_Proof": [
        "Balance of probabilities"
    ],
    "Defendant_Response": [
        "Non-infringement based on different process"
    ],
    "Evidence_Type": [
        "Technical evidence",
        "Process documentation"
    ],
    "Remedy_Requested": [
        "Injunction against Cobalt's marketing"
    ],
    "Outcome": [
        "Non-infringement; Bayer's claim dismissed"
    ],
    "Decision_Authority": [
        "Court"
    ],
    "Remedy_Sought": [
        "Prohibition of generic drug marketing"
    ],
    "Resolution_Mechanism": [
        "Judicial determination"
    ],
    "Legal_Provision": [
        "'137 patent, Claim 13"
    ],
    "Authority": [
        "Court with patent jurisdiction"
    ],
    "Claimant_Status": [
        "Patent holder (Bayer)"
    ],
    "Legal_Provision_Cited": [
        "'137 patent"
    ],
    "Grounds_for_Inadmissibility_or_Allegation": [
        "Lack of use of essential patented elements"
    ],
    "Applicable_Process": [
        "Patent infringement litigation"
    ],
    "Outcome_of_Review": [
        "No infringement established"
    ],
    "Pending_Relief_or_Application": [
        "Injunction application dismissed"
    ],
    "Jurisdiction": [
        "Patent court or equivalent judicial body"
    ],
    "Governing_Rule": [
        "Product-by-process claim interpretation rule"
    ]
}